Literature DB >> 32408829

Relationship Between Left Ventricular Geometry and Invasive Hemodynamics in Pediatric Pulmonary Hypertension.

Dale A Burkett1, Sonali S Patel1, Luc Mertens2, Mark K Friedberg2, D Dunbar Ivy1.   

Abstract

Background Ventricular septal flattening, frequently present in pulmonary hypertension (PH), can be quantified using eccentricity index (EI). EI has not been evaluated by concurrent echocardiography and cardiac catheterization and traditionally does not account for postsystolic septal flattening, often seen in PH. We evaluated left ventricular shape, including a novel measure of maximal EI to account for postsystolic septal flattening, to establish the relationship with concurrent invasive hemodynamics. Methods Echocardiography was performed at 2 institutions in 78 pediatric PH patients during cardiac catheterization and in 78 matched controls. From midpapillary parasternal short-axis views, EI and right-to-left ventricular diameter ratio were assessed. Results EI and right-to-left ventricular measures were significantly increased in PH compared with controls. Shape measures correlated with invasive hemodynamics and PH outcome measures (PH-related hospitalization, functional class, medical therapy escalation, and BNP [brain natriuretic peptide]). End-systolic EI of 1.16 best identified the presence of PH, whereas a maximal EI of 1.42 and 1.94 best identified half-systemic and systemic PH, respectively. A maximal EI of 1.27 was associated with an odds ratio of 16.16 (95% CI, 6.62-39.46) for PH-related hospitalization or escalation of therapy. Conclusions Using simultaneous echocardiography and catheterization in the largest study population to date, we demonstrate that EI and right-to-left ventricular ratio correlate with invasive hemodynamics and outcomes measures, and EI can accurately define those with clinically important PH. These measures strengthen the ability of echocardiography to identify and follow pediatric PH patients, especially in the absence of methods to quantify right ventricular systolic pressures.

Entities:  

Keywords:  cardiac catheterization; heart ventricles; natriuretic peptide, brain; outcome assessment, health care; ventricular septum

Mesh:

Year:  2020        PMID: 32408829      PMCID: PMC7236425          DOI: 10.1161/CIRCIMAGING.119.009825

Source DB:  PubMed          Journal:  Circ Cardiovasc Imaging        ISSN: 1941-9651            Impact factor:   7.792


  32 in total

1.  Addressing the Controversy of Estimating Pulmonary Arterial Pressure by Echocardiography.

Authors:  Myriam Amsallem; Joshua M Sternbach; Sasikanth Adigopula; Yukari Kobayashi; Thu A Vu; Roham Zamanian; David Liang; Gundeep Dhillon; Ingela Schnittger; Michael V McConnell; François Haddad
Journal:  J Am Soc Echocardiogr       Date:  2015-12-11       Impact factor: 5.251

2.  Differences in Eccentricity Index and Systolic-Diastolic Ratio in Extremely Low-Birth-Weight Infants with Bronchopulmonary Dysplasia at Risk of Pulmonary Hypertension.

Authors:  A W McCrary; J R Malowitz; C P Hornick; K D Hill; C M Cotten; G H Tatum; P C Barker
Journal:  Am J Perinatol       Date:  2015-07-14       Impact factor: 1.862

3.  Echo-Doppler evaluation of left ventricular impairment in chronic cor pulmonale.

Authors:  M Schena; E Clini; D Errera; A Quadri
Journal:  Chest       Date:  1996-06       Impact factor: 9.410

4.  Right ventricular to left ventricular diameter ratio at end-systole in evaluating outcomes in children with pulmonary hypertension.

Authors:  Pei-Ni Jone; Julie Hinzman; Brandie D Wagner; David Dunbar Ivy; Adel Younoszai
Journal:  J Am Soc Echocardiogr       Date:  2013-12-08       Impact factor: 5.251

5.  Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT).

Authors:  Nazzareno Galiè; Marius M Hoeper; Marc Humbert; Adam Torbicki; Jean-Luc Vachiery; Joan Albert Barbera; Maurice Beghetti; Paul Corris; Sean Gaine; J Simon Gibbs; Miguel Angel Gomez-Sanchez; Guillaume Jondeau; Walter Klepetko; Christian Opitz; Andrew Peacock; Lewis Rubin; Michael Zellweger; Gerald Simonneau
Journal:  Eur Heart J       Date:  2009-08-27       Impact factor: 29.983

6.  Ventricular geometry, strain, and rotational mechanics in pulmonary hypertension.

Authors:  Sarinya Puwanant; Margaret Park; Zoran B Popović; W H Wilson Tang; Samar Farha; Deepa George; Jacqueline Sharp; Jirapa Puntawangkoon; James E Loyd; Serpil C Erzurum; James D Thomas
Journal:  Circulation       Date:  2010-01-04       Impact factor: 29.690

7.  Clinical utility of echocardiography for the diagnosis and management of pulmonary vascular disease in young children with chronic lung disease.

Authors:  Peter M Mourani; Marci K Sontag; Adel Younoszai; D Dunbar Ivy; Steven H Abman
Journal:  Pediatrics       Date:  2008-02       Impact factor: 7.124

8.  Septal curvature is marker of hemodynamic, anatomical, and electromechanical ventricular interdependence in patients with pulmonary arterial hypertension.

Authors:  Francois Haddad; Julien Guihaire; Mehdi Skhiri; Andre Y Denault; Olaf Mercier; Shadi Al-Halabi; Bojan Vrtovec; Elie Fadel; Roham T Zamanian; Ingela Schnittger
Journal:  Echocardiography       Date:  2013-12-23       Impact factor: 1.724

9.  Aortopathy is prevalent in relatives of bicuspid aortic valve patients.

Authors:  Simon Biner; Asim M Rafique; Indraneil Ray; Olivera Cuk; Robert J Siegel; Kirsten Tolstrup
Journal:  J Am Coll Cardiol       Date:  2009-06-16       Impact factor: 24.094

10.  Paediatric pulmonary arterial hypertension: updates on definition, classification, diagnostics and management.

Authors:  Erika B Rosenzweig; Steven H Abman; Ian Adatia; Maurice Beghetti; Damien Bonnet; Sheila Haworth; D Dunbar Ivy; Rolf M F Berger
Journal:  Eur Respir J       Date:  2019-01-24       Impact factor: 16.671

View more
  6 in total

1.  End-Systolic Eccentricity Index Obtained by Enhanced Computed Tomography Is a Predictor of Pulmonary Vascular Resistance in Patients with Chronic Thromboembolic Pulmonary Hypertension.

Authors:  Yoshinori Tsutsumi; Shiro Adachi; Yoshihisa Nakano; Shingo Iwano; Shinji Abe; Katsuhiko Kato; Shinji Naganawa
Journal:  Life (Basel)       Date:  2022-04-17

Review 2.  Point-of-care ultrasound for children.

Authors:  Ko Ichihashi; Kazuhito Nonaka
Journal:  J Med Ultrason (2001)       Date:  2022-01-21       Impact factor: 1.314

3.  Impact of Diastolic Interventricular Septal Flattening on Clinical Outcome in Patients With Severe Tricuspid Regurgitation.

Authors:  Taku Omori; Mika Maeda; Shunsuke Kagawa; Goki Uno; Florian Rader; Robert J Siegel; Takahiro Shiota
Journal:  J Am Heart Assoc       Date:  2021-10-08       Impact factor: 5.501

Review 4.  Bronchopulmonary dysplasia from chest radiographs to magnetic resonance imaging and computed tomography: adding value.

Authors:  Nara S Higano; Alister J Bates; Chamindu C Gunatilaka; Erik B Hysinger; Paul J Critser; Russel Hirsch; Jason C Woods; Robert J Fleck
Journal:  Pediatr Radiol       Date:  2022-02-05

5.  Normal Echocardiographic Reference Values of the Right Ventricular to Left Ventricular Endsystolic Diameter Ratio and the Left Ventricular Endsystolic Eccentricity Index in Healthy Children and in Children With Pulmonary Hypertension.

Authors:  Sabrina Schweintzger; Stefan Kurath-Koller; Ante Burmas; Gernot Grangl; Andrea Fandl; Nathalie Noessler; Alexander Avian; Andreas Gamillscheg; Philippe Chouvarine; Georg Hansmann; Martin Koestenberger
Journal:  Front Cardiovasc Med       Date:  2022-07-14

6.  Echocardiographic Changes and Long-Term Clinical Outcomes in Pediatric Patients With Pulmonary Arterial Hypertension Treated With Bosentan for 72 Weeks: A Post-hoc Analysis From the FUTURE 3 Study.

Authors:  Maurice Beghetti; Rolf M F Berger; Damien Bonnet; Simon Grill; Catherine Lesage; Jean-Christophe Lemarie; D Dunbar Ivy
Journal:  Front Pediatr       Date:  2021-06-16       Impact factor: 3.418

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.